NCT07231822Recruiting
The Investigation of the Effectiveness of Virtual Reality Applications in Postmenopausal Osteoporosis Patients
The Investigation of the Effectiveness of Virtual Reality Applications in Postmenopausal Osteoporosis Patients: A Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 27 Feb 2026
Brief summary (registry, in English)
Osteoporosis is a progressive disease characterised by a decrease in bone mass, deterioration in bone microarchitecture, and increased fragility. Etiologically, it is divided into two types: primary (postmenopausal and senile) and secondary. Postmenopausal women are particularly at high risk; it is seen in more than 80% of women over the age of 50 and in almost all individuals over the age of 75. With menopause, bone mineral density decreases, which negatively affects neuromuscular functions, leading to balance disorders, decreased walking speed, and an increased risk of falls. Falls are the primary cause of osteoporotic fractures and result in functional loss, morbidity, mortality, and increased healthcare costs. Exercise is effective in reducing bone loss; in recent years, therapeutic virtual reality and exercise games (exergames) have come to the fore. However, the literature on the effectiveness of these applications in postmenopausal osteoporosis patients is limited. The aim of this study is to investigate the effects of virtual reality applications on balance, quality of life, and fall risk and to compare them with a control group.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- First submitted
- 14 Nov 2025
- Start date
- 20 Nov 2025
- Primary completion date
- 1 Mar 2026
- Lead sponsor
- Kirsehir Ahi Evran Universitesi
- Diseases
- Osteoporosis
- NCT number
- NCT07231822
What you commit to
- Study type: Interventional
- Planned participants: 50
- From 20 Nov 2025 to the primary completion date, 1 Mar 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Secondary osteoporosis diagnosis (e.g. endocrine, metabolic or drug-induced causes)
Other illness
- History of lower limb fracture or surgical intervention within the last 6 months
- Individuals with severe cardiovascular, neurological, or musculoskeletal disorders
Other
- Individuals with vestibular or visual impairments that may affect balance
- Intolerance to virtual reality applications (e.g., dizziness, nausea, etc.)
- Individuals who have participated in a regular physiotherapy or exercise programme within the last 3 months
Who the study is looking for
- Postmenopausal women aged 50-75 years
- Individuals diagnosed with osteoporosis based on Dual-Energy X-ray Absorptiometry (DEXA) measurement (T-score ≤ -2.5)
- Having been in menopause for at least 1 year
- Being able to walk independently (without the use of assistive devices)
- Volunteering to participate in the study and having provided informed consent
- Having adequate cognitive function (e.g., Mini Mental Test ≥ 24)
Age in the registry: 40 years to 65 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Kırşehir Ahi Evran University Coordinator of this site? Confirm its status | Center | Turkey (Türkiye) | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.